Flecainide Acetate

Thông số

54143-56-5Số CAS

258-997-5Số EC

acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamideTên IUPAC

C19H24F6N2O5Công thức hóa học

474.4 g/molKhối lượng phân tử

Flecainide acetate; 54143-56-5; FLECAINIDE MONOACETATE; R-818; R 818; DTXSID8020626; M8U465Q1WQ; Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, monoacetate; DTXCID80626; CHEBI:5091; NSC719273; RefChem:56567; Flecainide Acetate Tablet; N-((2RS)-Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; Tambocor; Flecainide (acetate); MFCD00214290; N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate; n-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate; MLS000069675; Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-,monoacetate; N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; N-(Piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; SMR000058451; Flecainide acetate salt; FLECAINIDEACETATE; 54143-56-5 (acetate); SR-01000000172; EINECS 258-997-5; UNII-M8U465Q1WQ; Flecainidacetat; Apocard; C19H24F6N2O5; Tambocor (TN); Flecainide acetate [USAN:USP:JAN]; N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide monoacetate; Flecainide (acetate)?; Flecainide acetate CRS; Opera_ID_1587; 2,5-Bis-(2,2,2-trifluoroethoxy)-N-(2-piperidinylmethyl)benzamide acetate; acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide acetate salt; CAS-54143-56-5; MLS001148177; MLS002222300; SCHEMBL121583; SCHEMBL308966; orb1224743; orb1299967; CHEMBL1200822; FLECAINIDE ACETATE [JAN]; Flecainide (acetate) (Standard); Flecainide acetate (JP17/USP); FLECAINIDE ACETATE [USAN]; FLECAINIDE ACETATE [VANDF]; GLXC-07604; HMS1570C12; HMS2097C12; HMS2231E15; HMS3259F11; HMS3267N04; HMS3369M07; HMS3412D09; HMS3676D09; HMS3714C12; FLECAINIDE ACETATE [MART.]; FLECAINIDE ACETATE [USP-RS]; FLECAINIDE ACETATE [WHO-DD]; Tox21_200208; EBC-44428; HY-17429R; Flecainide for system suitability CRS; AKOS015889993; N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide acetate; CCG-220735; CS-1400; FF36707; NC00641; SB19142; Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-, acetate (1:1); FLECAINIDE ACETATE [EP IMPURITY]; FLECAINIDE ACETATE [ORANGE BOOK]; FLECAINIDE ACETATE [EP MONOGRAPH]; FLECAINIDE ACETATE [USP IMPURITY]; NCGC00093934-01; NCGC00093934-02; NCGC00257762-01; AS-11702; FLECAINIDE ACETATE [USP MONOGRAPH]; HY-17429; DB-052497; EU-0100546; NS00076417; T7219; D00638; E-0735; F 6777; G60923; SR-01000000172-2; SR-01000000172-4; SR-01000000172-5; SR-01000000172-7; Q27089351; Flecainide acetate, British Pharmacopoeia (BP) Reference Standard; Flecainide acetate, European Pharmacopoeia (EP) Reference Standard; 2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide acetate; acetic acid;N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; Flecainide acetate, United States Pharmacopeia (USP) Reference Standard; 2-({[2,5-bis(2,2,2-trifluoroethoxy)benzoyl]amino}methyl)piperidinium acetate; Acetic acid--N-[(piperidin-2-yl)methyl]-2,5-bis(2,2,2-trifluoroethoxy)benzamide (1/1); Flecainide for system suitability, European Pharmacopoeia (EP) Reference Standard; N-[(RS)-(Piperidin-2-ylmethyl)]-2,5-bis(2,2,2- trifluoroethoxy)benzamide acetateTên gọi khác